Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

LUPIN vs TEVA PHARMA (Israel) - Comparison Results

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 LUPIN   TEVA PHARMA
EQUITY SHARE DATA
    LUPIN
Mar-23
TEVA PHARMA
Dec-13
LUPIN/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs7993,479-   
Low Rs5833,022-   
Sales per share (Unadj.) Rs365.81,996.4-  
Earnings per share (Unadj.) Rs9.8124.7-  
Cash flow per share (Unadj.) Rs29.2286.1-  
Dividends per share (Unadj.) Rs4.00109.18-  
Avg Dividend yield %0.63.4 17.2%  
Book value per share (Unadj.) Rs270.72,217.6-  
Shares outstanding (eoy) m454.98848.00-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.91.6 116.0%   
Avg P/E ratio x70.226.1 269.5%  
P/CF ratio (eoy) x23.711.4 208.3%  
Price / Book Value ratio x2.61.5 174.2%  
Dividend payout %40.787.5 46.4%   
Avg Mkt Cap Rs m314,3812,756,220 11.4%   
No. of employees `000NA44.9 0.0%   
Total wages/salary Rs m30,8720-   
Avg. sales/employee Rs Th037,667.6-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th02,353.1-  
INCOME DATA
Net Sales Rs m166,4171,692,969 9.8%  
Other income Rs m1,5090-   
Total revenues Rs m167,9261,692,969 9.9%   
Gross profit Rs m17,206463,620 3.7%  
Depreciation Rs m8,807136,844 6.4%   
Interest Rs m2,74333,253 8.2%   
Profit before tax Rs m7,165293,523 2.4%   
Minority Interest Rs m01,333 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-192,682 -0.0%   
Tax Rs m2,688-3,584 -75.0%   
Profit after tax Rs m4,477105,758 4.2%  
Gross profit margin %10.327.4 37.8%  
Effective tax rate %37.5-1.2 -3,072.8%   
Net profit margin %2.76.2 43.1%  
BALANCE SHEET DATA
Current assets Rs m124,5131,143,425 10.9%   
Current liabilities Rs m92,654997,163 9.3%   
Net working cap to sales %19.18.6 221.6%  
Current ratio x1.31.1 117.2%  
Inventory Days Days2691 28.9%  
Debtors Days Days9896 102.5%  
Net fixed assets Rs m103,490552,961 18.7%   
Share capital Rs m9104,167 21.8%   
"Free" reserves Rs m122,2460-   
Net worth Rs m123,1561,880,567 6.5%   
Long term debt Rs m275865,653 0.0%   
Total assets Rs m228,0033,868,976 5.9%  
Interest coverage x3.69.8 36.8%   
Debt to equity ratio x00.5 0.5%  
Sales to assets ratio x0.70.4 166.8%   
Return on assets %3.23.6 88.1%  
Return on equity %3.65.6 64.6%  
Return on capital %8.04.9 162.8%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m26,3060-   
CASH FLOW
From Operations Rs m18,972269,772 7.0%  
From Investments Rs m-12,868-95,591 13.5%  
From Financial Activity Rs m-3,373-323,609 1.0%  
Net Cashflow Rs m2,732-149,429 -1.8%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 83.34 Rs / USD

Compare LUPIN With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  

Compare LUPIN With: AMBALAL SARABHAI  ALCHEMIST LIMITED  RAJNISH WELLNESS  WOCKHARDT  BERYL DRUGS  



Today's Market

Sensex Today Rallies 550 Points| Nifty Tops 22,250 | Power Stocks Shine Sensex Today Rallies 550 Points| Nifty Tops 22,250 | Power Stocks Shine(10:30 am)

Asian markets traded lower, while the US stock indices ended higher overnight with the S&P 500 hitting a record closing high ahead of key economic data.